Market Insights Health Pharmacies OTC Products

Cold & Cough Remedies (Pharmacies) - Poland

Poland

Revenue in the Cold & Cough Remedies market is projected to reach €0.87bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.70%, resulting in a market volume of €1.32bn by 2029.
In global comparison, most revenue will be generated in China (€7,182.00m in 2024).
In relation to total population figures, per person revenues of €21.57 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Poland has been experiencing steady growth in recent years.

Customer preferences: Polish consumers have shown a growing preference for over-the-counter cold and cough remedies purchased from pharmacies. This shift in consumer behavior can be attributed to several factors. Firstly, the convenience of purchasing these remedies from pharmacies, which are easily accessible and often located in close proximity to residential areas. Secondly, the increasing awareness among consumers about the effectiveness and safety of over-the-counter cold and cough remedies. This has led to a greater trust in the products available in pharmacies. Lastly, the affordability of these remedies compared to prescription medications has also contributed to their popularity among consumers.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Poland is the rising demand for natural and herbal remedies. Consumers are increasingly seeking products that are perceived to be more natural and have fewer side effects. This trend is in line with the global shift towards natural and organic products. As a result, pharmacies in Poland are expanding their product offerings to include a wider range of natural and herbal remedies for cold and cough. Another trend in the market is the increasing availability of private label products. Pharmacies in Poland are increasingly launching their own private label brands of cold and cough remedies. This trend is driven by the desire to offer more affordable options to consumers, as well as to differentiate themselves from competitors. Private label products also allow pharmacies to have more control over the quality and pricing of their offerings.

Local special circumstances: Poland has a well-established pharmacy network, with a high density of pharmacies across the country. This makes it convenient for consumers to access cold and cough remedies from their local pharmacies. Additionally, the Polish government has implemented regulations to ensure the quality and safety of over-the-counter medications sold in pharmacies. This has further increased consumer trust in these products.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies (Pharmacies) market in Poland can be attributed to several underlying macroeconomic factors. Firstly, Poland has experienced steady economic growth in recent years, which has led to an increase in disposable income among consumers. This has resulted in higher spending on healthcare products, including cold and cough remedies. Secondly, the aging population in Poland has also contributed to the growth of the market. As the population ages, the demand for healthcare products, including remedies for cold and cough, is expected to increase. Lastly, the increasing prevalence of cold and cough-related illnesses in Poland has also driven the demand for remedies in the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Poland is experiencing growth due to consumer preferences for over-the-counter remedies, the rising demand for natural and herbal products, the availability of private label brands, the convenience of the pharmacy network, and underlying macroeconomic factors such as economic growth, an aging population, and the prevalence of cold and cough-related illnesses.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.